Tag: Swiss Supplementary Protection Certificate

MLL Legal defended Bristol-Myers Squibbs’ Supplementary Protection Certificate for apixaban

The patent team of MLL Legal successfully defended Bristol-Myers Squibbs’ Swiss Supplementary Protection Certificate (SPC) for the active pharmaceutical ingredient apixaban, comprised in the blockbuster anticoagulant Eliquis®.